Benzinga's Top Downgrades
Analysts at Piper Jaffray downgraded Cepheid (NASDAQ: CPHD) from “overweight” to “neutral.” Cepheid's shares closed at $34.09 yesterday. Cepheid's trailing-twelve-month ROE is -12.52%.
Analysts at Deutsche Bank downgraded Abbott Laboratories (NYSE: ABT) from “buy” to “hold.” Abbott's shares closed at $33.27 yesterday. Abbott's PEG ratio is 0.51.
Analysts at Goldman Sachs downgraded Wells Fargo & Company (NYSE: WFC) from “buy” to “neutral.” Wells Fargo's shares closed at $34.76 yesterday. Wells Fargo's trailing-twelve-month profit margin is 23.18%.
Raymond James downgraded First Solar (NASDAQ: FSLR) from “market perform” to “underperform.” First Solar's shares closed at $34.41 yesterday. First Solar's trailing-twelve-month ROA is 2.17%.
Latest Ratings for CPHD
|Dec 2014||Bank of America||Upgrades||Neutral||Buy|
© 2015 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.